Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies
-
By
-
Jiazhong Wang
-
Gang Cao
-
Yang Liu
-
Hao Qiao
-
Qiao He
-
Bo Zheng
-
June 22, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
MD Anderson Cancer Center
Houston, Texas
-
#2
Memorial Sloan Kettering Cancer Center
New York, New York
-
#3
Massachusetts General Hospital
Boston, Massachusetts
-
#4
University of California, Los Angeles
Los Angeles, California
-
#5
Weill Cornell Medical Center
New York, New York
